Arcus Biosciences, Inc.
Clinical trials sponsored by Arcus Biosciences, Inc., explained in plain language.
Biotech developing cancer immunotherapies.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Liver health and drug processing: a closer look at casdatifan
Knowledge-focused Not yet recruitingThis study is testing how the body processes a single dose of casdatifan, an experimental drug, in people with moderate liver impairment compared to healthy volunteers. The goal is to see if liver function changes how the drug is absorbed and cleared from the body. Participants r…
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New drug AB102 enters first human safety tests
Knowledge-focused Not yet recruitingThis early-stage trial is the first to test AB102 in humans. It will give the drug to 130 healthy volunteers to check its safety and how the body processes it. The study is not designed to treat any disease, but to gather essential information for future research.
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC